AAHRPP Accredits First Organizations in India
The Association for the Accreditation of Human Research Protection Programs, Inc. announced that it has accredited another seven organizations—including its first organizations in India.
Four of the seven newly accredited organizations are outside the United States, underscoring AAHRPP's progress in moving toward one standard worldwide for protecting research participants. All told, 241 organizations have now earned accreditation, including institutions in 45 states, the District of Columbia, Puerto Rico, Canada, China, India, Korea, and Singapore.
The latest accreditations come as AAHRPP celebrates the 10th anniversary of its founding in 2001 and prepares to mark 10 years since the issuance of the first accreditation standards in 2002.
"The goal, a decade ago, was to establish an accrediting organization to strengthen research protections and improve the quality of research," said Marjorie A. Speers, PhD, AAHRPP President and CEO. "Since then, hundreds of organizations have earned the AAHRPP gold seal, demonstrating their commitment to rigorous standards that help protect research participants while ensuring that society continues to reap the benefits of research."
The newly accredited organizations are:
Creighton University, Omaha, Nebraska, USA
Diex Research Sherbrooke, Inc. & Diex Research Montreal, Inc., Sherbrooke, Quebec, Canada
IRB Services, Aurora, Ontario, Canada
Kasturba Hospital, Manipal, Manipal, India
Manipal Hospital Bangalore, Bangalore, India
Texas Health Resources, Arlington, Texas, USA
The University of Alabama, Tuscaloosa, Alabama, USA
For these and all accredited organizations, AAHRPP accreditation translates into significant benefits for research participants and society as a whole.
Accreditation is available to United States and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. The list of accredited organizations includes community and teaching hospitals; VA facilities, universities; institutional review boards; research institutes; and contract research organizations.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
